What is InBrace?
InBrace operates at the intersection of medtech and orthodontics, having developed a sophisticated smart wire system that automates tooth movement. By moving beyond the limitations of traditional braces and clear aligners, the company has carved out a distinct niche in the dental health sector. Its market position is bolstered by a strong intellectual property portfolio and a clinical approach that prioritizes patient comfort and treatment efficiency. As a high-growth entity, InBrace continues to scale its operations, leveraging its unique technological advantage to capture significant market share within the global orthodontic industry.
How much funding has InBrace raised?
InBrace has raised a total of $218.6M across 6 funding rounds:
Series A
$5.6M
Series B
$20M
Series C
$45M
Debt
$1M
Series D
$102M
Debt
$45M
Series A (2017): $5.6M, investors not publicly disclosed
Series B (2018): $20M, investors not publicly disclosed
Series C (2019): $45M supported by Novo Holdings, venBio Partners, and Vivo Capital
Debt (2020): $1M featuring PPP
Series D (2021): $102M backed by Marshall Wace, Soleus Capital, Farallon Capital Management, MVM Partners, BlackRock, RTW Investments, and Endeavour Vision
Debt (2022): $45M with participation from Horizon Technology Finance
Key Investors in InBrace
BlackRock
BlackRock is a global investment management firm providing institutional clients with comprehensive asset management, risk management, and advisory services across diverse asset classes.
Soleus Capital
Soleus Capital is a healthcare-focused investment firm specializing in innovative life sciences sectors, including medtech and genomics, targeting both developmental and commercial-stage companies.
MVM Partners
MVM Partners is a healthcare investment firm that partners with management teams to drive growth in medical technology and digital health, aiming to address significant unmet needs in large markets.
What's next for InBrace?
Following its recent capital infusion, InBrace is well-positioned to accelerate its commercial expansion and deepen its penetration into the orthodontic market. The strategic focus will likely shift toward scaling manufacturing capabilities, expanding clinical partnerships, and potentially exploring new applications for its smart wire platform. Given the company's history of securing backing from top-tier healthcare and life sciences investors, the path forward involves maintaining its competitive edge through continuous innovation and operational excellence. The firm remains a key player to watch as it transitions from a high-growth startup to a dominant force in modern dental care.
See full InBrace company page
